Raju Sunagar
Overview
Explore the profile of Raju Sunagar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sunagar R, Singh A, Kumar S
Vaccines (Basel)
. 2023 Apr;
11(4).
PMID: 37112761
The global rollout of COVID-19 vaccines has played a critical role in reducing pandemic spread, disease severity, hospitalizations, and deaths. However, the first-generation vaccines failed to block severe acute respiratory...
2.
Sunagar R, Prasad S, Ella R, Vadrevu K
Front Immunol
. 2022 Dec;
13:1063679.
PMID: 36569867
Most if not all vaccine candidates developed to combat COVID-19 due to SARS-CoV-2 infection are administered parenterally. As SARS-CoV-2 is transmitted through infectious respiratory fluids, vaccine-induced mucosal immunity could provide...
3.
Kumar S, Sunagar R, Gosselin E
Vaccines (Basel)
. 2020 Apr;
8(2).
PMID: 32340134
Lack of safe and effective mucosal adjuvants has severely hampered the development of mucosal subunit vaccines. In this regard, we have previously shown that immunogenicity of vaccine antigens can be...
4.
Kumar S, Sunagar R, Gosselin E
Front Immunol
. 2019 Jun;
10:1144.
PMID: 31191528
Adjuvants have been used in vaccines for over a century, however, the search for safe and effective vaccine adjuvants continues. In recent decades toll-like-receptor (TLR) agonists have been investigated as...
5.
Sunagar R, Kumar S, Namjoshi P, Rosa S, Hazlett K, Gosselin E
PLoS One
. 2018 Dec;
13(12):e0207587.
PMID: 30533047
Francisella tularensis (Ft) is a biothreat agent for which there is no FDA-approved human vaccine. Currently, there are substantial efforts underway to develop both vaccines and the tools to assess...
6.
Sunagar R, Kumar S, Rosa S, Hazlett K, Gosselin E
Front Immunol
. 2018 Jul;
9:1594.
PMID: 30042767
() is a biothreat agent for which there is no FDA-approved human vaccine. Currently, there are substantial efforts underway to develop both vaccines and improved tools to assess these vaccines....
7.
Holland K, Rosa S, Kristjansdottir K, Wolfgeher D, Franz B, Zarrella T, et al.
Front Microbiol
. 2017 Jul;
8:1158.
PMID: 28690600
The gram-negative bacterium () is both a potential biological weapon and a naturally occurring microbe that survives in arthropods, fresh water amoeba, and mammals with distinct phenotypes in various environments....
8.
Kumar S, Sunagar R, Pham G, Franz B, Rosa S, Hazlett K, et al.
Front Immunol
. 2017 Jan;
7:677.
PMID: 28119692
() is a category A biothreat agent for which there is no Food and Drug Administration-approved vaccine. can survive in a variety of habitats with a remarkable ability to adapt...
9.
Kumar S, Sunagar R, Pham G, Gosselin E, Nalin D
Vaccine
. 2017 Jan;
35(7):1080-1086.
PMID: 28069362
Numerous studies have demonstrated that administration of antigen (Ag)-pulsed dendritic cells (DCs) is an effective strategy for enhancing immunity to tumors and infectious disease organisms. However, the generation and/or isolation...
10.
Sunagar R, Hegde N, Archana G, Sinha A, Nagamani K, Isloor S
J Glob Antimicrob Resist
. 2016 Sep;
7:46-52.
PMID: 27598056
Methicillin-resistant Staphylococcus aureus (MRSA) is a serious human pathogen that can cause a wide variety of infections. Comparative genetic analyses have led to the discovery that despite the existence of...